CongressTrades

REGN

PHARMACEUTICAL PREPARATIONS

Regeneron Pharmaceuticals, Inc. - Common Stock (REGN) [ST]

www.regeneron.com ↗
$782.04

▲ 2.23%

prev close

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; Kevzara in rheumatoid arthritis; and Lynozyfic for multiple myeloma. Regeneron has multiple partnerships and collaboration agreements, with Sanofi (Dupixent, others) and Bayer (Eylea) as its largest partners.

Congressional Trades

16

All tracked trades

Members Trading

8

Unique members

Net Activity

-6

5 buys · 11 sells

Members Who Traded This Stock

16 trade events

2026-05-15

Gilbert Cisneros

REGN

Sell

Amount

$1,001 - $15,000

Filed

134d ago

2026-02-12

Julia Letlow

REGN

Buy

Amount

$1,001 - $15,000

Filed

222d ago

2025-11-18

Gilbert Cisneros

REGN

Buy

Amount

$1,001 - $15,000

Filed

309d ago

2025-04-08

Rob Bresnahan

REGN

Sell

Amount

$1,001 - $15,000

Filed

530d ago

2025-04-07

Jefferson Shreve

REGN

Sell

Amount

$15,001 - $50,000

Filed

530d ago

2025-02-12

Julie Johnson

REGN

Sell

Amount

$1,001 - $15,000

Filed

587d ago

2025-01-24

Josh Gottheimer

REGN

Sell

Amount

$1,001 - $15,000

Filed

617d ago

2025-01-15

Julie Johnson

REGN

Buy

Amount

$1,001 - $15,000

Filed

615d ago

2024-11-19

Josh Gottheimer

REGN

Sell

Amount

$1,001 - $15,000

Filed

684d ago

2024-11-13

Jonathan Jackson

REGN

Sell

Amount

$15,001 - $50,000

Filed

677d ago

2024-10-15

Greg Landsman

REGN

Sell

Amount

$1,001 - $15,000

Filed

705d ago

2023-11-13

Josh Gottheimer

REGN

Sell

Amount

$1,001 - $15,000

Filed

1047d ago

2023-08-21

Josh Gottheimer

REGN

Buy

Amount

$1,001 - $15,000

Filed

1130d ago

2023-07-11

Josh Gottheimer

REGN

Buy

Amount

$1,001 - $15,000

Filed

1156d ago

2023-06-22

Josh Gottheimer

REGN

Sell

Amount

$1,001 - $15,000

Filed

1197d ago

2023-03-06

Josh Gottheimer

REGN

Sell

Amount

$1,001 - $15,000

Filed

1279d ago

Recent News

Powered by Polygon.io

Forget Eli Lilly and Novo: This Biotech Could Be a Surprising Winner in the Weight Loss Market

The Motley Fool·2026-10-19

Forget Eylea: Regeneron's Real Value May Be Hiding in Its Dupixent Profit Share

The Motley Fool·2026-10-17

Libtayo® (cemiplimab) Recommended for EU Approval by the CHMP for Updated Dosing Regimen Across All Approved Cancer Types

GlobeNewswire Inc.·2026-10-16

Can Nektar's Pipeline Progress Create Long-Term Value Amid Rivalry?

Zacks Investment Research·2026-10-15

Here's Why You Should Add EYPT Stock to Your Portfolio Now

Zacks Investment Research·2026-10-15

Trade Timeline

Congressional activity, newest first

Gilbert Cisneros

2026-05-15 · Sale

$1,001 - $15,000

Julia Letlow

2026-02-12 · Purchase

$1,001 - $15,000

Gilbert Cisneros

2025-11-18 · Purchase

$1,001 - $15,000

Rob Bresnahan

2025-04-08 · Sale

$1,001 - $15,000

Jefferson Shreve

2025-04-07 · Sale

$15,001 - $50,000

Julie Johnson

2025-02-12 · Sale

$1,001 - $15,000

Josh Gottheimer

2025-01-24 · Sale

$1,001 - $15,000

Julie Johnson

2025-01-15 · Purchase

$1,001 - $15,000

Josh Gottheimer

2024-11-19 · Sale

$1,001 - $15,000

Jonathan Jackson

2024-11-13 · Sale

$15,001 - $50,000

Greg Landsman

2024-10-15 · Sale

$1,001 - $15,000

Josh Gottheimer

2023-11-13 · Sale

$1,001 - $15,000

Josh Gottheimer

2023-08-21 · Purchase

$1,001 - $15,000

Josh Gottheimer

2023-07-11 · Purchase

$1,001 - $15,000

Josh Gottheimer

2023-06-22 · Sale

$1,001 - $15,000

Josh Gottheimer

2023-03-06 · Sale

$1,001 - $15,000